| Shareholder | |||
|---|---|---|---|
| 北京百洋同興管理諮詢有限公司 | 17.07% | 101.99M | |
| FU GANG | 17.07% | 101.99M | |
| WuXi Biologics (Cayman) Inc. | 16.27% | 96.86M | |
| James Qun XueExecutive Director | 13.23% | 56.19M | |
| WuXi AppTec Co., Ltd. | 9.51% | 40.35M | |
| Schulte-Hillen Friedrich Bela | 5.97% | 12.62M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| FU GANG | +3.06M | 2.60 | Bought | 101.99M | 17.07% | ||
| 北京百洋同興管理諮詢有限公司 | +3.06M | 2.60 | Bought | 101.99M | 17.07% | ||
| 北京百洋匯康科技創新發展有限公司 | +3.06M | 2.60 | Bought | 101.99M | 17.07% | ||
| Baheal Pharma Group Co., Ltd. | +3.06M | 2.60 | Bought | 101.99M | 17.07% | ||
| Qingdao Baheal Medical Inc. | +3.06M | 2.60 | Bought | 101.99M | 17.07% | ||
| Baheal Wellness Industry International Trading Limited | +3.06M | 2.60 | Bought | 101.99M | 17.07% |
This page shows the major shareholders of CANBRIDGE-B (01228) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

